We are live on ! Find out more
NVNO

enVVeno Medical
NVNO

7 hedge funds and large institutions have $164K invested in enVVeno Medical in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

556% more capital invested

Capital invested by funds: $25K → $164K (+$139K)

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

75% more funds holding

Funds holding: 4 → 7 (+3)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
7
Holders Change
+3
Holders Change %
+75%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$102K
2
UBS Group
UBS Group
Switzerland
+$19.9K
3
Northern Trust
Northern Trust
Illinois
+$7.3K
4
TSS
Two Sigma Securities
New York
+$5.97K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$7K
2
Victory Capital Management
Victory Capital Management
Texas
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$104K +$102K +309 New
UBS Group
2
UBS Group
Switzerland
$20K +$19.9K +60 New
GIA
3
Gladstone Institutional Advisory
Florida
$15K – – –
Northern Trust
4
Northern Trust
Illinois
$7K +$7.3K +22 New
Osaic Holdings
5
Osaic Holdings
Arizona
$6K – – –
TSS
6
Two Sigma Securities
New York
$6K +$5.97K +18 New
VF
7
Virtu Financial
New York
$6K +$5.97K +18 New
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
– -$7K -26 Closed
Victory Capital Management
9
Victory Capital Management
Texas
– -$2K -6 Closed

NVNO Hedge Fund Activity: Q2 2020 in Review

7 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q2 2020, worth a combined $164K — up 556% from $25K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new NVNO positions and 2 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $102K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $7K sold.

  • 7 institutional investors held enVVeno Medical (NVNO) as of Q2 2020, up from 4 in Q1 2020.
  • Funds reported $164K of enVVeno Medical stock for Q2 2020, up 556% quarter-over-quarter.
  • 5 funds opened new enVVeno Medical positions in Q2 2020 and 2 closed out, a net change of +3 holders.
  • The largest enVVeno Medical buyer in Q2 2020 was Renaissance Technologies, an estimated $102K added.
  • The largest enVVeno Medical seller in Q2 2020 was Susquehanna International Group, an estimated $7K sold.

Based on aggregated 13F filings for Q2 2020.